Advertisement
Review Article| Volume 26, ISSUE 4, P625-627, October 2010

Gastrointestinal System and Obesity

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Critical Care Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • El-Serag H.
        Role of obesity in GORD-related disorders.
        Gut. 2008; 57: 281-284
        • Corley D.A.
        • Kubo A.
        • Zhao W.
        Abdominal obesity, ethnicity and gastro-oesophageal reflux symptoms.
        Gut. 2007; 56: 756-762
        • Nilsson M.
        • Johnsen R.
        • Ye W.
        • et al.
        Obesity and estrogen as risk factors for gastroesophageal reflux symptoms.
        JAMA. 2003; 290: 66-72
        • Suter M.
        • Dorta G.
        • Giusti V.
        • et al.
        Gastro-esophageal reflux and esophageal motility disorders in morbidly obese patients.
        Obes Surg. 2004; 14: 959-966
        • Castell D.O.
        Obesity and gastro-oesophageal reflux: is there a relationship?.
        Eur J Gastroenterol Hepatol. 1996; 8: 625-626
        • Friedenberg F.K.
        • Xanthopoulos M.
        • Foster G.D.
        • et al.
        The association between gastroesophageal reflux disease and obesity.
        Am J Gastroenterol. 2008; 103: 2111-2122
        • Kolbel C.B.
        • Rippel K.
        • Klar H.
        • et al.
        Esophageal motility disorders in critically ill patients: a 24-hour manometric study.
        Intensive Care Med. 2000; 26: 1421-1427
        • Quigley E.M.
        Critical care dysmotility: abnormal foregut motor function in the ICU/ITU patient.
        Gut. 2005; 54 ([discussion: 1384–90]): 1351-1352
        • Gallagher T.K.
        • Geoghegan J.G.
        • Baird A.W.
        • et al.
        Implications of altered gastrointestinal motility in obesity.
        Obes Surg. 2007; 17: 1399-1407
        • Kalinowski C.P.
        • Kirsch J.R.
        Strategies for prophylaxis and treatment for aspiration.
        Best Pract Res Clin Anaesthesiol. 2004; 18: 719-737
        • Muscedere J.
        • Dodek P.
        • Keenan S.
        • et al.
        Comprehensive evidence-based clinical practice guidelines for ventilator-associated pneumonia: prevention.
        J Crit Care. 2008; 23: 126-137
        • Andrews A.D.
        • Brock-Utne J.G.
        • Downing J.W.
        Protection against pulmonary acid aspiration with ranitidine. A new histamine H2-receptor antagonist.
        Anaesthesia. 1982; 37: 22-25
        • Frezza E.E.
        • Shebani K.O.
        • Robertson J.
        • et al.
        Morbid obesity causes chronic increase of intraabdominal pressure.
        Dig Dis Sci. 2007; 52: 1038-1041
        • Lambert D.M.
        • Marceau S.
        • Forse R.A.
        Intra-abdominal pressure in the morbidly obese.
        Obes Surg. 2005; 15: 1225-1232
        • Malbrain M.L.
        • Cheatham M.L.
        • Kirkpatrick A.
        • et al.
        Results from the International Conference of Experts on Intra-abdominal Hypertension and Abdominal Compartment Syndrome. I. Definitions.
        Intensive Care Med. 2006; 32: 1722-1732
        • Browning J.D.
        • Szczepaniak L.S.
        • Dobbins R.
        • et al.
        Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity.
        Hepatology. 2004; 40: 1387-1395
        • Nugent C.
        • Younossi Z.M.
        Evaluation and management of obesity-related nonalcoholic fatty liver disease.
        Nat Clin Pract Gastroenterol Hepatol. 2007; 4: 432-441
        • Pillai A.A.
        • Rinella M.E.
        Non-alcoholic fatty liver disease: is bariatric surgery the answer?.
        Clin Liver Dis. 2009; 13: 689-710
        • Levin P.D.
        • Weissman C.
        Obesity, metabolic syndrome, and the surgical patient.
        Med Clin North Am. 2009; 93: 1049-1063
        • Rafiq N.
        • Bai C.
        • Fang Y.
        • et al.
        Long-term follow-up of patients with nonalcoholic fatty liver.
        Clin Gastroenterol Hepatol. 2009; 7: 234-238
        • Foreman M.G.
        • Mannino D.M.
        • Moss M.
        Cirrhosis as a risk factor for sepsis and death: analysis of the National Hospital Discharge Survey.
        Chest. 2003; 124: 1016-1020
        • Kramer L.
        • Jordan B.
        • Druml W.
        • et al.
        Incidence and prognosis of early hepatic dysfunction in critically ill patients–a prospective multicenter study.
        Crit Care Med. 2007; 35: 1099-1104
        • Tsai C.J.
        • Leitzmann M.F.
        • Willett W.C.
        • et al.
        Macronutrients and insulin resistance in cholesterol gallstone disease.
        Am J Gastroenterol. 2008; 103: 2932-2939